Research Appraisalobservational

Artificial intelligence-powered H&E-based quantification of spatial tumor-infiltrating lymphocyte distribution identifies prognostic immune niches in colorectal cancer

Cancer immunology, immunotherapy : CIIKoh, Hyun-Hee, Lee, Seungeun, Oum, Chiyoon et al.4 May 2026DOI

Clinical Snapshot

75CEBM
Evidence: Moderateobservational

PICO Framework

P — Population202 patients with stage II-III colorectal cancer
I — InterventionAI-based spatial analysis of tumor-infiltrating lymphocytes (TILs) from H&E-stained tissue sections
C — ComparatorConventional pathologist assessment and Immunoscore
O — OutcomesRecurrence-free survival, prognostic performance of spatial TIL distribution patterns

Bottom Line

This prognostic cohort study of 202 stage II-III colorectal cancer patients demonstrates that spatial analysis of tumor-infiltrating lymphocytes using standard H&E slides can predict recurrence-free survival. The novel tumor-stromal border (TSB) score showed independent prognostic value comparable to the established Immunoscore, particularly in microsatellite instability-high tumors. While the approach shows promise for improving risk stratification using routine pathology specimens, the study lacks external validation and has a relatively small sample size. The commercial involvement and single-center design limit immediate clinical adoption. Australian pathologists should await validation studies before incorporating this technology into routine practice, though the use of standard H&E staining makes it potentially feasible for implementation in existing laboratory workflows.

Evidence: Moderate

Key Findings

  • P Value: TIL score p=0.001, TSB score p<0.001, Immunoscore p<0.001

  • Effect Size: TIL score, TSB score, and Immunoscore all independently predictive

  • Primary Outcome: Recurrence-free survival

  • Nnt Or Sensitivity: AI-pathologist correlation: iTIL r=0.57, sTIL r=0.70

  • Confidence Interval: Not reported in abstract

Clinical Application

Requires H&E slides and specialized software, potentially implementable in pathology laboratories Could complement existing pathology workflows in Australian hospitals; may require TGA approval for diagnostic software; relevant for RACGP cancer surveillance guidelines Patients with stage II-III colorectal cancer undergoing surgical resection

Abstract

PURPOSE: The prognostic significance of tumor-infiltrating lymphocytes (TILs) in colorectal cancer (CRC) is well established; however, existing approaches inadequately capture their spatial distribution. We investigated the prognostic implications of TIL spatial distribution in CRC using an artificial intelligence (AI)-based method. METHODS: A total of 202 patients with stage II-III CRC were included. TIL densities in intratumoral (iTIL) and stromal (sTIL) regions were quantified using AI-based analysis of hematoxylin and eosin (H&E)-stained images. Based on proximity to the tumor-stromal border (TSB), TILs were subclassified into core iTIL, bounding iTIL, bounding sTIL, and outermost sTIL. Immunoscore was calculated from CD3+ and CD8+ T-cell densities in the tumor center and invasive margin. RESULTS: Correlations between AI-based and pathologist assessments (iTIL: r = 0.57; sTIL: r = 0.70) were comparable to inter-pathologist correlations (iTIL: r = 0.47; sTIL: r = 0.70). In univariate Cox regression analysis, bounding iTIL, bounding sTIL, and outermost sTIL were significantly associated with recurrence-free survival (RFS), whereas core iTIL was not. Composite TIL and TSB scores were developed by incorporating the prognostically significant regions. In multivariable analysis, the TIL score (p = 0.001), TSB score (p < 0.001), and Immunoscore (p < 0.001) independently predicted RFS. In microsatellite instability-high tumors, only the TSB score remained prognostically significant. CONCLUSION: AI-powered spatial analysis of TILs, particularly the TSB score, demonstrated prognostic performance comparable to conventional Immunoscore, thereby supporting the value of spatial immune profiling and AI-driven analysis of H&E-stained slides for improved risk stratification in CRC.

References

  1. 1.Koh, H. H., Lee, S., Oum, C., Song, S., Cho, S. I., Pereira, S., Ahn, C. H., Kim, J. Y., Kim, M., & Jung, M. (2026). Artificial intelligence-powered H&E-based quantification of spatial tumor-infiltrating lymphocyte distribution identifies prognostic immune niches in colorectal cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.3390/cancers12102902
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service